Risk of macular degeneration with statin use should be interpreted with caution.
作者信息
van Leeuwen R, Vingerling J R, de Jong P T
出版信息
BMJ. 2001 Dec 1;323(7324):1308.
Abstract
摘要
相似文献
1
Risk of macular degeneration with statin use should be interpreted with caution.
BMJ. 2001 Dec 1;323(7324):1308.
2
[Use of statins as a form of protection against age-related macular degeneration (AMD)].
Klin Oczna. 2008;110(1-3):50-4.
3
Recent statin use and 1-year incidence of exudative age-related macular degeneration.
Am J Ophthalmol. 2010 Jun;149(6):955-958.e1. doi: 10.1016/j.ajo.2009.12.037. Epub 2010 Mar 26.
4
Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration.
Am J Ophthalmol. 2004 Oct;138(4):697; author reply 697-8. doi: 10.1016/j.ajo.2004.05.063.
5
Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among age-related macular degeneration patients.
Am J Ophthalmol. 2004 Dec;138(6):1089; author reply 1090. doi: 10.1016/j.ajo.2004.08.048.
6
Do statins prevent age-related macular degeneration?
Am J Ophthalmol. 2004 Apr;137(4):747-9. doi: 10.1016/j.ajo.2004.01.037.
7
Statins and age-related macular degeneration.
Am J Ophthalmol. 2004 Oct;138(4):688; author reply 688-9. doi: 10.1016/j.ajo.2004.05.015.
8
Statins do not decrease the risk for wet age-related macular degeneration.
Curr Eye Res. 2009 Apr;34(4):304-10. doi: 10.1080/02713680902741670.
9
Statins: much more than just a lipid-lowering therapy.
Indian Heart J. 2004 May-Jun;56(3):204-9.
10
Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration.
Am J Ophthalmol. 2004 Apr;137(4):615-24. doi: 10.1016/j.ajo.2003.10.025.
引用本文的文献
1
Do statins have a role in the prevention of age-related macular degeneration?
Drugs Aging. 2013 Apr;30(4):205-13. doi: 10.1007/s40266-013-0061-4.
2
The Rotterdam Study: 2012 objectives and design update.
Eur J Epidemiol. 2011 Aug;26(8):657-86. doi: 10.1007/s10654-011-9610-5. Epub 2011 Aug 30.
3
The Rotterdam Study: 2010 objectives and design update.
Eur J Epidemiol. 2009;24(9):553-72. doi: 10.1007/s10654-009-9386-z.
4
Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study.
Am J Ophthalmol. 2007 Mar;143(3):473-83. doi: 10.1016/j.ajo.2006.11.058. Epub 2007 Jan 10.
5
Mouse models may provide new insight into the relation between cholesterol and age related macular degeneration.
Br J Ophthalmol. 2005 Dec;89(12):1549-51. doi: 10.1136/bjo.2005.077370.
6
A case control study of age related macular degeneration and use of statins.
Br J Ophthalmol. 2005 Sep;89(9):1171-5. doi: 10.1136/bjo.2004.064477.
7
The association between statin use and age related maculopathy.
Br J Ophthalmol. 2003 Sep;87(9):1121-5. doi: 10.1136/bjo.87.9.1121.
本文引用的文献
1
Risk of macular degeneration in users of statins: cross sectional study.
BMJ. 2001 Aug 18;323(7309):375-6. doi: 10.1136/bmj.323.7309.375.
2
The prevalence of age-related maculopathy in the Rotterdam Study.
Ophthalmology. 1995 Feb;102(2):205-10. doi: 10.1016/s0161-6420(95)31034-2.
3
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.
Surv Ophthalmol. 1995 Mar-Apr;39(5):367-74. doi: 10.1016/s0039-6257(05)80092-x.
Zotero 插件